Long-term treatment with belimumab among patients with systemic lupus erythematosus is associated with reduced organ damage compared to treatment with background therapy alone, a new study shows.
Long-term treatment with belimumab among patients with systemic lupus erythematosus is associated with reduced organ damage compared to treatment with background therapy alone, a new study shows.
Long-term treatment with...
